Physician profile
John Tarro
NPI 1942294749
$3,907.39
in general payments reported to CMS, 2019-2025
18 companies · $1,707 in 2025
The $1,707 reported for 2025 was more than what 87% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $502 · 2020: $156 · 2021: $39.92 · 2022: $12.50 · 2023: $242 · 2024: $1,247 · 2025: $1,707.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,152 · Education: $45.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,151.79 |
| Education | $45.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,345.28 | 2024-2025 | Inspire |
| Glaxosmithkline, LLC. | $662.43 | 2019-2025 | Nucala |
| Genzyme Corporation | $506.50 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $464.03 | 2019-2025 | Dupixent |
| Astrazeneca Pharmaceuticals Lp | $288.51 | 2019-2025 | Airsupra, Fasenra, Tezspire |
| Optinose US, INC. | $201.58 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $93.40 | 2019-2020 | |
| Stryker Corporation | $51.92 | 2022-2025 | Xpress Loprofile |
| Paratek Pharmaceuticals, INC. | $38.86 | 2025 | Xhance |
| Ethicon US, LLC | $38.26 | 2025 | Vistaseal, Surgicel Nu-Knit, Surgiflo Hemostatic Matrix |
| Aerin Medical INC. | $38.12 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $34.23 | 2025 | Keytruda |
| Covidien Lp | $33.83 | 2019 | |
| Medtronic USA, INC. | $31.86 | 2019 | |
| Kaleo, INC. | $29.33 | 2019-2023 | Auvi-Q |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $19.08 | 2019 | |
| Smith+Nephew, INC. | $16.78 | 2021 | |
| Axogen | $13.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Tarro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.